Find the Perfect Plan for Your Investment Journey
G
Latest price
52 Week Range
€20.00 - €31.08
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | €1.51B |
EV | €-1.77B |
Shares Outstanding | 65.90M |
Beta | -0.01 |
Analyst Rating | HOLD |
Analyst Target Price | €32.04 |
P/E 2025E | - |
P/Revenue 2025E | 5.52x |
Revenue | -17.20% |
EPS | - |
Operating Cash Flow | 13.40% |
Free Cash Flow | 15.00% |
Revenue | -2.70% |
EPS | - |
Operating Cash Flow | 11.90% |
Free Cash Flow | - |
Gross Margin 2025E | 100.00% |
Net Profit Margin 2025E | -62.11% |
ROE 2025E | -3.66% |
ROCE 2024 | -0.05% |
DPS 2025E | €0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
G
Galapagos NV
GLPG
Sector
Healthcare
Industry
Biotechnology
CEO
Stoffels, Paulus
Employees
704
Website
www.glpg.comIPO Date
2005-05-06
Headquarters
Generaal De Wittelaan L11 A3, Mechelen, Antwerp, 2800, Belgium
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved